Primary prophylaxis of esophageal variceal bleeding in cirrhosis

Gastroenterologie Clinique et Biologique

Volumn 32, Issue 5 SUPPL. PART 1, 2008, Pages 532-540

  Bellot, P ^a   Garcia Pagan J C ^a   Abraldes, J G ^a   Bosch, J ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE DINITRATE; NADOLOL; PROPRANOLOL DERIVATIVE; SPIRONOLACTONE;

CLINICAL PRACTICE; DISEASE SEVERITY; ENDOSCOPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; PROPHYLAXIS; RISK REDUCTION; SHORT SURVEY;

DECISION TREES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; RISK FACTORS;

EID: 50649086156     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2008.03.012     Document Type: Short Survey

References (69)

1. D'Amico G., and de Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
2. D'Amico G. Esophageal varices: from appearance to rupture; natural history and prognostic indicators. In: Groszmann R.J., and Bosch J. (Eds). Portal hypertension in the 21st century (2004), Kluwer Academic Publishers, Dordrecht 147-154
3. Merli M., Nicolini G., Angeloni S., Rinaldi V., De S.A., Merkel C., et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 38 (2003) 266-272
4. Groszmann R.J., Garcia-Tsao G., Bosch J., Escorsell A., Garcia-Pagan J.C., Grace N.D., et al. Multicenter randomized placebo-controlled trial of non-selective beta-blockers in the prevention of the complications of portal hypertension: Final results and identification of a predictive factor (abstract). Hepatology 38 Suppl. 1 (2003) 206A
5. NIEC. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 319 (1988) 983-989
6. Merkel C., Zoli M., Siringo S., van Buuren H., Magalotti D., Angeli P., et al. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol 95 (2000) 2915-2920
7. Grace N.D., Groszmann R.J., Garcia-Tsao G., Bosch J., Burroughs A.K., Pagliaro L., et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 28 (1998) 868-880
8. Viallet A., Marleau D., Huet M., Martin F., Farley A., Villeneuve J.P., et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology 69 (1975) 1297-1300
9. Garcia-Tsao G., Groszmann R.J., Fisher R.L., Conn H.O., Atterbury C.E., and Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 5 (1985) 419-424
10. Casado M., Bosch J., Garcia-Pagan J.C., Bru C., Banares R., Bandi J.C., et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 114 (1998) 1296-1303
11. Groszmann R.J., Bosch J., Grace N.D., Conn H.O., Garcia-Tsao G., Navasa M., et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage [see comments]. Gastroenterology 99 (1990) 1401-1407
12. Feu F., Garcia-Pagan J.C., Bosch J., Luca A., Teres J., Escorsell A., et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 21 346 (1995) 1056-1059
13. Vorobioff J., Groszmann R.J., Picabea E., Gamen M., Villavicencio R., Bordato J., et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology 111 (1996) 701-709
14. Merkel C., Bolognesi M., Sacerdoti D., Bombonato G., Bellini B., Bighin R., et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 32 (2000) 930-934
15. Villanueva C., Balanzo J., Novella M.T., Soriano G., Sainz S., Torras X., et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 20 334 (1996) 1624-1629
16. Villanueva C., Minana J., Ortiz J., Gallego A., Soriano G., Torras X., et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 30 345 (2001) 647-655
17. Escorsell A., Bordas J.M., Castaneda B., Llach J., Garcia-Pagan J.C., Rodes J., et al. Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension. Hepatology 31 (2000) 1061-1067
18. Abraldes J.G., Tarantino I., Turnes J., Garcia-Pagan J.C., Rodes J., and Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 37 (2003) 902-908
19. Villanueva C., Lopez-Balaguer J.M., Aracil C., Kolle L., Gonzalez B., Minana J., et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol 40 (2004) 757-765
20. D'Amico G., Garcia-Pagan J.C., Luca A., and Bosch J. HVPG reduction and prevention of variceal bleeding in cirrhosis. A systematic review. Gastroenterology 131 (2006) 1611-1624
21. Giannini E., Botta F., Borro P., Risso D., Romagnoli P., Fasoli A., et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut 52 (2003) 1200-1205
22. Kazemi F., Kettaneh A., N'kontchou G., Pinto E., Ganne-Carrie N., Trinchet J.C., et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 45 (2006) 230-235
23. Foucher J., Chanteloup E., Vergniol J., Castéra L., Le Bail B., Adhoute X., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 55 (2006) 403-408
24. Bosch J. Predictions from a hard liver. J Hepatol 45 (2006) 174-177
25. de Franchis R. Evolving consensus in portal hypertension report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43 (2005) 167-176
26. Bosch J., D'Amico G., and García-Pagán J.C. Portal hypertension. In: Schiff E.R., Sorrell M.F., and Maddrey W.C. (Eds). Schiff's diseases of the liver. 9th ed. (2002), Lippincott Williams & Wilkins, Philadelphia 429-486
27. D'Amico G., Pasta L., Madonia S., Tarantino I., Mancuso A., Malizia G., et al. The incidence of esophageal varices in cirrhosis (abstract). Gastroenterology 120 Suppl. 1 (2001) A2
28. Garcia-Tsao G., D'Amico G., Abraldes J.G., Schepis F., Merli M., Kim W.R., et al. Predictive models in portal hypertension. In: de Franchis R. (Ed). Proceedings of the fourth Baveno International Consensus Workshop on definitions, methodology and therapeutic strategies (2005), Blackwell-Science, Oxford 47-100
29. Pagliaro L., D'Amico G., Sorensen T.I., Lebrec D., Burroughs A.K., Morabito A., et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Intern Med 117 (1992) 59-70
30. Lin H.C., Soubrane O., Cailmail S., and Lebrec D. Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats. J Hepatol 13 (1991) 213-219
31. Sarin S.K., Groszmann R.J., Mosca P.G., Rojkind M., Stadecker M.J., Bhatnagar R., et al. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension. J Clin Invest 87 (1991) 1032-1036
32. Groszmann R.J., Garcia-Tsao G., Bosch J., Grace N.D., Burroughs A.K., Planas R., et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 24 353 (2005) 2254-2261
33. Cales P., Oberti F., Payen J.L., Naveau S., Guyader D., Blanc P., et al. Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol 11 (1999) 741-745
34. Merkel C., Marin R., Angeli P., Zanella P., Felder M., Bernardinello E., et al. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology 127 (2004) 476-484
35. D'Amico G., Pagliaro L., and Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 19 (1999) 475-505
36. Poynard T., Cales P., Pasta L., Ideo G., Pascal J.P., Pagliaro L., et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 324 (1991) 1532-1538
37. Abraczinskas D.R., Ookubo R., Grace N.D., Groszmann R.J., Bosch J., Garcia-Tsao G., et al. Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?. Hepatology 34 (2001) 1096-1102
38. Gengo F.M., Huntoon L., and McHugh W.B. Lipid-soluble and water-soluble beta-blockers. Comparison of the central nervous system depressant effect. Arch Intern Med 147 (1987) 39-43
39. Garcia-Pagan J., Morillas R.M., Bañares R., Albillos A., Villanueva C., Vila C., et al. Propranolol plus placebo vs propranolol plus isosorbide-5-mononitrate in the prevention of the first variceal bleed. A double blind RCT. Hepatology 37 (2003) 1260-1266
40. Garcia-Pagan J.C., Villanueva C., Vila M.C., Albillos A., Genesca J., Ruiz-del-Arbol L., et al. Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers. Gastroenterology 121 (2001) 908-914
41. Garcia-Pagan J.C., Feu F., Bosch J., and Rodes J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. Ann Intern Med 114 (1991) 869-873
42. Merkel C., Sacerdoti D., Bolognesi M., Enzo E., Marin R., Bombonato G., et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta- blocker alone. Hepatology 26 (1997) 34-39
43. Merkel C., Marin R., Sacerdoti D., Donada C., Cavallarin G., Torboli P., et al. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 31 (2000) 324-329
44. Merkel C., Marin R., Enzo E., Donada C., Cavallarin G., Torboli P., et al. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP). Lancet 348 (1996) 1677-1681
45. Garcia-Pagan J.C., Salmeron J.M., Feu F., Luca A., Gines P., Pizcueta P., et al. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology 19 (1994) 1095-1099
46. Abecasis R., Kravetz D., Fassio E., Ameigeiras B., Garcia D., Isla R., et al. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study. Hepatology 37 (2003) 359-365
47. Borroni G., Salerno F., Cazzaniga M., Bissoli F., Lorenzano E., Maggi A., et al. Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites. J Hepatol 37 (2002) 315-321
48. Laine L., and Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 123 (1995) 280-287
49. Imperiale T.F., and Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 33 (2001) 802-807
50. Chen C.Y., Sheu M.Z., Tsai T.L., and Lin Y.L. Endoscopic variceal ligation with multiple band ligator for prophylaxis of first hemorrage esophageal varices (abstract). Endoscopy 31 Suppl. 1 (1999) E35
51. Schepke M., Kleber G., Nurnberg D., Willert J., Koch L., Veltzke-Schlieker W., et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 40 (2004) 65-72
52. Abdelfattah M.H., Rashed M.A., Elfakhry A.A., Soliman M.A., and Shiha G.H. Endoscopic variceal ligation versus pharmacologic treatment for primary prophylaxis of variceal bleeding: a randomised study (abstract). J Hepatol 44 (2006) S83
53. Song H., Shin J.W., Kim H.I., Choi J., Lim C.Y., Kim J.W., et al. A prospective randomized trial between the prophylactic endoscopic variceal ligation and propranolol administration for prevention of first bleeding in cirrhotic patients with high risk esophageal varices (abstract). J Hepatology 32 Suppl. 2 (2000) 41A
54. Sarin S.K., Lamba G.S., Kumar M., Misra A., and Murthy N.S. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 340 (1999) 988-993
55. de la Mora, Farca-Belsaguy A.A., Uribe M., and de Hoyos-Garza A. Ligation vs propranolol for primary prophylaxis of variceal bleeding using multiple band ligator and objective measurements of treatment adequacy: preliminary results (abstract). Gastroenterology 118 (2000) 6511A
56. Lui H.F., Stanley A.J., Forrest E.H., Jalan R., Hislop W.S., Mills P.R., et al. Primary prophylaxis of variceal hemorrhage: A randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 123 (2002) 735-744
57. Lo G.H., Chen W.C., Chen M.H., Lin C.P., Lo C.C., Hsu P.I., et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc 59 (2004) 333-338
58. Jutabha R., Jensen D.M., Martin P., Savides T.J., Chapman L., and Jensen M.E. A randomized, prospective study of prophylactic rubber band ligation compared to propranolol for prevention of first variceal hemorraghe in cirrhotic with large esophageal varices (abstract). Gastrointest Endosc 53 (2001) 70A
59. Thuluvath P.J., Maheshwari A., Jagannath S., and Arepally A. A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Dig Dis Sci 50 (2005) 407-410
60. De B.K., Ghoshal U.C., Das T., Santra A., and Biswas P.K. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 14 (1999) 220-224
61. Drastich P., Lata J., Petrtyl J., Prochazka V., Vanasek T., Zdenek P., et al. Endoscopic variceal band ligation in comparison with propranolol in prophylaxis of first variceal bleeding in patients with liver cirrhosis (abstract). J Hepatol 42 (2005) 79
62. Lay C.S., Tsai Y.T., Lee F.Y., Lai Y.L., Yu C.J., Chen C.B., et al. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis. J Gastroenterol Hepatol 21 (2006) 413-419
63. Khuroo M.S., Khuroo N.S., Farahat K.L., Khuroo Y.S., Sofi A.A., and Dahab S.T. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 21 (2005) 347-361
64. Triantos C., Vlachogiannakos J., Armonis A., Saveriadis A., Kougioumtzian A., Leandro G., et al. Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation. Aliment Pharmacol Ther 211 (2005) 435-443
65. Turnes J., García-Pagán J.C., Abraldes J.G., Dell'Era A., Hernandez-Guerra M., Bosch J., et al. Pharmacological reduction of portal pressure and long term risk of first variceal bleeding in patients with cirrhosis (abstract). Hepatology 38 (2003) 219A
66. Arguedas M.R., Heudebert G.R., Eloubeidi M.A., Abrams G.A., and Fallon M.B. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol 97 (2002) 2441-2452
67. Saab S., DeRosa V., Nieto J., Durazo F., Han S., and Roth B. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. Am J Gastroenterol 98 (2003) 763-770
68. Teran J.C., Imperiale T.F., Mullen K.D., Tavill A.S., and McCullough A.J. Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. Gastroenterology 112 (1997) 473-482
69. Sarin S.K., Wadhawan M., Agarwal S.R., Tyagi P., and Sharma B.C. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 100 (2005) 797-804